4Moving Biotech at OARSI 2025

Prof. Francis Berenbaum, Chief Medical Officer at 4Moving Biotech takes the stage at OARSI2025!
We can’t wait to share how 4Moving Biotech is moving from lab to clinic with our intra‑articular GLP‑1 candidate designed to change the course of osteoarthritis.

🗣️ Clinical Trial Symposium. Title: “From Discovery to Delivery: Advancing Intraarticular GLP‑1‑Based Therapeutics in Osteoarthritis”

📍 Incheon, South Korea
📅 24–27 April 2025